Cogent Biosciences Inc (COGT): Next-Year EPS Estimate 65.17%
As of 2026-06-04, Cogent Biosciences Inc (COGT) has a next-year EPS growth estimate of 65.17%.
On 2026-06-01, analyst consensus for COGT's next-year EPS growth shifted from 65.02% to 65.17% — a positive change of 0.15 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at -3.94%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 65.17%
- EPS growth this year
- -3.94%
- EPS next quarter (est)
- -$0.55
- Last price
- $32.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 65.17% | -3.94% | -$0.55 | $32.79 |
| 2026-06-03 | 65.17% | -3.94% | -$0.55 | $32.26 |
| 2026-06-02 | 65.17% | -3.94% | -$0.55 | $32.76 |
| 2026-06-01 | 65.17% | -3.94% | -$0.55 | $34.81 |
| 2026-05-31 | 65.02% | -3.86% | -$0.55 | $34.96 |
| 2026-05-28 | 65.02% | -3.86% | -$0.55 | $35.38 |
| 2026-05-27 | 65.71% | -3.86% | -$0.55 | $34.51 |
| 2026-05-26 | 65.71% | -3.86% | -$0.55 | $33.94 |
| 2026-05-25 | 65.71% | -3.86% | -$0.55 | $32.67 |
| 2026-05-24 | 65.71% | -3.86% | -$0.55 | $32.67 |
| 2026-05-21 | 65.71% | -3.86% | -$0.55 | $32.58 |
| 2026-05-20 | 65.71% | -3.86% | -$0.55 | $32.92 |
| 2026-05-19 | 65.71% | -3.86% | -$0.55 | $31.25 |
| 2026-05-18 | 65.71% | -3.86% | -$0.55 | $31.36 |
| 2026-05-17 | 65.71% | -3.86% | -$0.55 | $32.68 |
| 2026-05-14 | 65.71% | -3.86% | -$0.55 | $34.19 |
| 2026-05-13 | 65.71% | -3.86% | -$0.55 | $34.37 |
| 2026-05-12 | 65.71% | -3.86% | -$0.55 | $34.53 |
| 2026-05-11 | 65.71% | -3.86% | -$0.55 | $34.10 |
| 2026-05-10 | 65.71% | -3.86% | -$0.55 | $34.74 |
| 2026-05-07 | 65.71% | -3.86% | -$0.55 | $34.79 |
| 2026-05-06 | 66.71% | -0.98% | -$0.54 | $35.87 |
| 2026-05-05 | 69.71% | 1.91% | -$0.51 | $36.98 |
| 2026-05-04 | 70.03% | 0.72% | -$0.53 | $36.73 |
| 2026-05-03 | 70.03% | 0.72% | -$0.53 | $36.63 |
| 2026-04-30 | 70.03% | 0.72% | -$0.53 | $35.79 |
| 2026-04-29 | 70.03% | 0.72% | -$0.53 | $35.87 |
| 2026-04-28 | 70.03% | 0.72% | -$0.53 | $36.34 |
| 2026-04-27 | 70.03% | 0.72% | -$0.53 | $36.60 |
| 2026-04-26 | 70.03% | 0.72% | -$0.53 | $36.81 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Cogent Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Cogent Biosciences Inc (COGT) has a next-year EPS growth estimate of 65.17%, based on analyst consensus.
When was the latest EPS estimate revision for COGT?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 65.02% to 65.17%.
What sector and industry does Cogent Biosciences Inc belong to?▾
Cogent Biosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. COGT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Cogent Biosciences Inc (COGT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports